Medicines and Healthcare products Regulatory Agency approves the usage of the Pfizer–BioNTech COVID-19 vaccine for people between the ages of 12 and 15
The Medicines and Healthcare products Regulatory Agency approves the usage of the Pfizer–BioNTech COVID-19 vaccine for people between the ages of 12 and 15, making it the first vaccine to be approved for use in teenagers in the UK.
Herald Premium Archive
This report is for subscribers
Sign in or choose a plan to read this report and the complete Premium retrospective archive.
HealthMedicines and Healthcare products Regulatory Agency approves the usage of the Pfizer–BioNTech COVID-19 vaccine for people between the ages of 12 and 15
View Premium plansBrowse free archive reportsThe Medicines and Healthcare products Regulatory Agency approves the usage of the Pfizer–BioNTech COVID-19 vaccine for people between the ages of 12 and 15, making it the first vaccine to be approved for use in teenagers in the UK.